University of Illinois at Chicago
College of Pharmacy
Department of Pharmacy Practice
833 S Wood Street, Rm164 (M/C 886)
Chicago, IL 60612
Pharmacogenomics Laboratory Website: http://www.uic.edu/pharmacy/depts/Pharmacogenomics_Laboratory/index.php
Bishop JR, Ellingrod VL, Moline J, Miller D. Association between the polymorphic GRM3 gene and olanzapine response. Schizophrenia Research 2005; 77:253-260.
Bishop JR, Ellingrod VL, Moline J, Miller D. Association between G-protein beta subunit (GNB3) polymorphisms and weight gain and clinical response to olanzapine. Medical Science Monitor 2006; 12:47-50.
Yin Y-C, Ellingrod VL, Bishop JR, Miller D. The relationship between olanzapine and P-glycoprotein (PGP) in schizophrenia. Therapeutic Drug Monitoring 2006; 28:668-672.
Bishop JR, Ellingrod VL, Moline J, Schultz SK, Clayton AH. Association between polymorphisms of the G-protein beta subunit (GNB3) and serotonin-2A receptor polymorphisms and sexual dysfunction in persons treated with an SSRI for depression. Neuropsychopharmacology 2006; 31:2281-2288.
Ellingrod VL, Bishop JR, Moline J, Miller D. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacology Bulletin 2007; 40:57-62.
Bishop JR, Wang K, Moline J, Ellingrod VL. Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatric Genetics 2007; 17:358.
Bishop JR and Pavuluri MN. Review of Risperidone for the Treatment of Pediatric and Adolescent Bipolar Disorder and Schizophrenia. Neuropsychiatric Disease and Treatment 2008; 4:55-68.
Reilly JL, Lencer R, Bishop JR, Keedy S, Sweeney JA. Pharmacological treatment effects on eye movement control. Brain and Cognition 2008; 68:415-435.
Bishop JR, Ellingrod VL, Akroush M, Moline J. The Association of Serotonin Transporter Genotypes and Selective Serotonin Reuptake Inhibitor (SSRI) Associated Sexual Side Effects: Possible Relationship to Oral Contraceptives. Human Psychopharmacology: Clinical and Experimental 2009; 24:207-215.
Hill SK, Bishop JR, Palumbo D, Sweeney JA. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert Review of Neurotherapeutics 2010; 10:43-57
Hong IS, Bishop JR. Anticholinergic use in children and adolescents taking antipsychotics. Annals of Pharmacotherapy 2010; 44:1171-80.
Sundermann E, Maki PM, Bishop JR. A Review of Estrogen Receptor-α Gene (ESR1) Polymorphisms, Mood, and Cognition. Menopause 2010; 17:874-86.
Thomas KLH, Ellingrod VL, Bishop JR, Keiser MJ. A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. Psychopharmacology Bulletin 2010; 43:11-22.
Bishop JR and Chae S. Should you order genetic testing to identify poor metabolizers in patients taking antipsychotics? Current Psychiatry 2010 9: 32-35.
Osis L and Bishop JR. Pharmacogenetics of SSRIs and Sexual Dysfunction. Pharmaceuticals 2010 3:3614-3628.
Houston J, Dharia S, Bishop JR, Ellingrod VL, Fijal B, Jacobsen JG, Hoffman VP. Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women. J Psychiatry Res (In Press).
Jeffrey R. Bishop, PharmD, BCPP
Assistant Professor of pharmacy practice and Psychiatry
College of Psychiatric and Neurologic Pharmacists, American College of Clinical Pharmacy
Psychopharmacology and Pharmacogenomics
Antipsychotic pharmacogenetics: cognition and symptom response, Risperidone-induced prolactin elevation and bone turnover, Genetic Predictors of Cognition and Mood in HIV+ Women